ERBB2 and breast cancer: Furthermore, these results were consistent with those from the scRNA-seq analysis (Figure S3a) and the trajectory analysis by scRNA-seq data (Figure S4b), which indicated that after the emergence of the migratory subtype, additional CNV accumulation occurred and led to the development of the secretory or proliferating subtypes in HR+/HER2-BC.